NON-SMALL CELL LUNG CANCER METASTATIC
Clinical trials for NON-SMALL CELL LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lung cancer patients with lung scarring: trial tests safer treatments
Disease control Not yet recruitingThis study is for people with advanced non-small cell lung cancer who also have interstitial lung disease (ILD), a condition that causes lung scarring. Many doctors avoid treating these patients due to risks of worsening ILD. The trial will test a specific chemotherapy as first t…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could chemo plus immunotherapy double the punch against tough lung cancers?
Disease control Not yet recruitingThis phase 3 trial investigates whether adding platinum-based chemotherapy to the immunotherapy drug tislelizumab helps people with a specific type of advanced lung cancer live longer without the disease worsening. Participants have non-small cell lung cancer that has spread, sho…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE3 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can zapping the main tumor boost survival in advanced lung cancer?
Disease control Not yet recruitingThis study looks at people with advanced non-small cell lung cancer that has spread to many places (more than five spots). It tests whether adding high-precision radiation to the main lung tumor, on top of standard drug therapy, helps them live longer and keeps the tumor from gro…
Matched conditions: NON-SMALL CELL LUNG CANCER METASTATIC
Phase: NA • Sponsor: Guizhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC